Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Carbohydrate doai
Reexamination Certificate
2005-03-08
2005-03-08
Wilson, James O. (Department: 1623)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Carbohydrate doai
C536S046000, C564S218000
Reexamination Certificate
active
06864246
ABSTRACT:
The invention concerns more particularly dodecylthio-phenylacetanilide derivative complexes such as (S)-2′,3′,5′-trimethyl-4′-hydroxy-α-dodecylthio-phenylacetanilide or related derivatives thereof and cyclodextrins.
REFERENCES:
patent: 0 070 368 (1983-01-01), None
patent: 9719918 (1997-06-01), None
Oota et al. (JP 06219909) (Abstract Sent).*
Didier Junquero et al., “Pharmacological profile of F 12511, (S)-2‘,3’,5‘-trimethyl-4’-hydroxy-α-dodecylthioacetanilide a powerful and systemic acylcoenzyme A: cholesterol acyltransferase inhibitor”, Biochemical Pharmacology, 2001, pp. 97-108, vol. 61.
Shuichi Takamura et al., “Anticholesteremic ethyl α-(p-chlorophenoxy)isobutyrate-β-cyclodextrin compound”, 6001 Chemical Abstracts, Mar., 11, 1975, vol. 83, No. 18, XP-002182063.
Bougáret Joël
Gil Alexandre
Ibarra Marie-Dominique
Leverd Elie
Heller Ehrman White and McAuliffe LLP
Henry Michael C.
Pierre Fabre Medicament
Wilson James O.
LandOfFree
Anilide and cyclodextrin complexes, their preparation and... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Anilide and cyclodextrin complexes, their preparation and..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Anilide and cyclodextrin complexes, their preparation and... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3435434